Limits...
The Potential Impact of Preventive HIV Vaccines in China: Results and Benefits of a Multi-Province Modeling Collaboration.

Harmon T, Guo W, Stover J, Wu Z, Kaufman J, Schneider K, Liu L, Feng L, Schwartländer B - Vaccines (Basel) (2015)

Bottom Line: China's commitment to implementing established and emerging HIV/AIDS prevention and control strategies has led to substantial gains in terms of access to antiretroviral treatment and prevention services, but the evolving and multifaceted HIV/AIDS epidemic in China highlights the challenges of maintaining that response.This study presents modeling results exploring the potential impact of HIV vaccines in the Chinese context at varying efficacy and coverage rates, while further exploring the potential implications of vaccination programs aimed at reaching populations at highest risk of HIV infection.A preventive HIV vaccine would add a powerful tool to China's response, even if not 100% efficacious or available to the full population.

View Article: PubMed Central - PubMed

Affiliation: International AIDS Vaccine Initiative, 125 Broad St., 9th Floor, New York, NY 10004, USA. tharmon@iavi.org.

ABSTRACT
China's commitment to implementing established and emerging HIV/AIDS prevention and control strategies has led to substantial gains in terms of access to antiretroviral treatment and prevention services, but the evolving and multifaceted HIV/AIDS epidemic in China highlights the challenges of maintaining that response. This study presents modeling results exploring the potential impact of HIV vaccines in the Chinese context at varying efficacy and coverage rates, while further exploring the potential implications of vaccination programs aimed at reaching populations at highest risk of HIV infection. A preventive HIV vaccine would add a powerful tool to China's response, even if not 100% efficacious or available to the full population.

No MeSH data available.


Related in: MedlinePlus

HIV Progression.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4494240&req=5

vaccines-03-00001-f007: HIV Progression.

Mentions: Newly infected individuals are in the primary stage for three months and are more infectious than people in other stages. An infected individual passes out of the primary stage and enters the asymptomatic stage, where he or she remains for 8 years with a low level of infectiousness. Finally, an infected individual moves to the symptomatic infectious stage for two or more years, before dying from AIDS. (Figure A3).


The Potential Impact of Preventive HIV Vaccines in China: Results and Benefits of a Multi-Province Modeling Collaboration.

Harmon T, Guo W, Stover J, Wu Z, Kaufman J, Schneider K, Liu L, Feng L, Schwartländer B - Vaccines (Basel) (2015)

HIV Progression.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4494240&req=5

vaccines-03-00001-f007: HIV Progression.
Mentions: Newly infected individuals are in the primary stage for three months and are more infectious than people in other stages. An infected individual passes out of the primary stage and enters the asymptomatic stage, where he or she remains for 8 years with a low level of infectiousness. Finally, an infected individual moves to the symptomatic infectious stage for two or more years, before dying from AIDS. (Figure A3).

Bottom Line: China's commitment to implementing established and emerging HIV/AIDS prevention and control strategies has led to substantial gains in terms of access to antiretroviral treatment and prevention services, but the evolving and multifaceted HIV/AIDS epidemic in China highlights the challenges of maintaining that response.This study presents modeling results exploring the potential impact of HIV vaccines in the Chinese context at varying efficacy and coverage rates, while further exploring the potential implications of vaccination programs aimed at reaching populations at highest risk of HIV infection.A preventive HIV vaccine would add a powerful tool to China's response, even if not 100% efficacious or available to the full population.

View Article: PubMed Central - PubMed

Affiliation: International AIDS Vaccine Initiative, 125 Broad St., 9th Floor, New York, NY 10004, USA. tharmon@iavi.org.

ABSTRACT
China's commitment to implementing established and emerging HIV/AIDS prevention and control strategies has led to substantial gains in terms of access to antiretroviral treatment and prevention services, but the evolving and multifaceted HIV/AIDS epidemic in China highlights the challenges of maintaining that response. This study presents modeling results exploring the potential impact of HIV vaccines in the Chinese context at varying efficacy and coverage rates, while further exploring the potential implications of vaccination programs aimed at reaching populations at highest risk of HIV infection. A preventive HIV vaccine would add a powerful tool to China's response, even if not 100% efficacious or available to the full population.

No MeSH data available.


Related in: MedlinePlus